The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 14, 2025

Filed:

Apr. 29, 2022
Applicant:

Hoffmann-la Roche Inc., Little Falls, NJ (US);

Inventors:

Katharina Lechner, Munich, DE;

Thomas Francis Moore, Starnberg, DE;

Martin Weisser, Penzberg, DE;

Natalie Dimier, Welwyn Garden City, GB;

David John Carlile, Princes Riborough, GB;

Nassim Djebli, Rixheim, FR;

Peter Nabil Morcos, Marlboro, NJ (US);

Linda Maria Lundberg, Binningen, CH;

Assignee:

Hoffmann-La Roche Inc., Little Falls, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 47/68 (2017.01); A61P 35/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2887 (2013.01); A61K 47/68031 (2023.08); A61K 47/6849 (2017.08); A61P 35/00 (2018.01); C07K 16/2803 (2013.01); C07K 16/2809 (2013.01); A61K 2039/507 (2013.01); A61K 2039/545 (2013.01); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/35 (2013.01); C07K 2317/55 (2013.01);
Abstract

The present invention relates to the treatment of subjects having CD20-positive cell proliferative disorders (e.g., B cell proliferative disorders, such as non-Hodgkin's lymphomas). More specifically, the invention pertains to the treatment of subjects having a CD20-positive cell proliferative disorder (e.g., B cell proliferative disorder) by administering a combination of an anti-CD20/anti-CD3 bispecific antibody and an anti-CD79b antibody drug conjugate.


Find Patent Forward Citations

Loading…